Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AFC-HD AMS Life Science Co., Ltd. ( (JP:2927) ) has issued an update.
AFC-HD AMS Life Science Co., Ltd. reported a notable increase in its financial performance for the fiscal year ending August 2025. The company achieved an 8.2% increase in net sales and a 25.7% rise in operating profit compared to the previous year, indicating strong operational growth and improved profitability. The company’s comprehensive income also saw a significant rise of 37.8%, reflecting its robust financial health and strategic positioning in the market.
The most recent analyst rating on (JP:2927) stock is a Buy with a Yen970.00 price target. To see the full list of analyst forecasts on AFC-HD AMS Life Science Co., Ltd. stock, see the JP:2927 Stock Forecast page.
More about AFC-HD AMS Life Science Co., Ltd.
AFC-HD AMS Life Science Co., Ltd. operates in the general business category and is listed on the Tokyo Stock Exchange Standard market. The company is involved in the life sciences industry, focusing on products and services that cater to health and wellness.
Average Trading Volume: 41,408
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen12.11B
Find detailed analytics on 2927 stock on TipRanks’ Stock Analysis page.